• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

CMS expands Medicare coverage to CGMs that integrate with Medtronic insulin pumps

December 22, 2021 By Sean Whooley

Medtronic World Diabetes Day
[Image from Medtronic]
Medtronic (NYSE:MDT) announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) will expand coverage for CGMs.

CMS’ expanded coverage covers all types of CGMs (continuous glucose monitors), including adjunctive and non-adjunctive CGMs, and it notably covers CGMs that integrate with Medtronic insulin pumps.

According to a news release, the proposed rule was finalized yesterday (December 21) and will be effective starting 60 days after official publication.

The expanded coverage also ensures the continuity of therapy for users on certain Medtronic insulin pump systems transitioning into Medicare, including Medtronic’s hybrid closed-loop systems that automatically adjust insulin delivery based on readings from the integrated CGM.

Medtronic said it intends to continue to offer its CGM access discount to all Medicare customers until the ruling goes into effect.

“We commend CMS for taking action to help more people with diabetes and empowering them to choose the therapies that best meet their diabetes management needs,” VP of Health Economics, Reimbursement & Government Affairs for Medtronic’s Diabetes Business Jeff Farkas said in the release. “This is a very important benefit expansion for our customers who have experienced significant clinical and quality of life benefits from their integrated Medtronic insulin pump systems and are now able to receive coverage for all components of their system on Medicare.”

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: Centers for Medicare and Medicaid Services (CMS), Medtronic, Reimbursement

IN CASE YOU MISSED IT

  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • Sequel Med Tech expects full twiist launch in the fall
  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS